PM 015
Alternative Names: PM-015Latest Information Update: 28 Feb 2024
At a glance
- Originator Boehringer Ingelheim; Phoremost
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Feb 2024 No recent reports of development identified for research development in Unspecified in Germany
- 28 Feb 2024 No recent reports of development identified for research development in Unspecified in United Kingdom
- 08 Jan 2020 Early research in Unspecified in United Kingdom, Germany (unspecified route) (PhorMost pipeline, January 2020)